44 results
8-K
EX-1.2
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
believes to be (i) a QIB or (ii) an institutional “accredited investor”.
Section 2. Engagement of Placement Agents; Fees; Expenses.
(a) Engagement … to place the Shares and the PFWs as contemplated by this Agreement. The Company acknowledges that the Placement Agents’ engagement hereunder does
8-K
EX-99.1
w5ghz0ujqkwoede8
10 Jul 23
Regulation FD Disclosure
4:06pm
424B5
dr9zss v1or
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
nejh0 z9npgxm8acsg7
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-10.1
75g2d4p8pq82uiw8m4
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
424B5
wbh vdf44xv8e
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
nc3jge4ea mi9
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
m9pdh
15 Nov 19
Departure of Directors or Certain Officers
4:37pm
8-K
EX-10.1
86xph oqwfd
15 Nov 19
Departure of Directors or Certain Officers
4:37pm